New therapies finding their place in management of follicular lymphomaNovember 5, 2015Indolent Lymphoma
Brentuximab changes landscape for post-transplant Hodgkin’s lymphoma patientsDecember 7, 2014Aggressive Lymphomas
PD-1 checkpoint inhibitors show mettle against relapsed Hodgkin’s lymphomaDecember 7, 2014Aggressive Lymphomas
VIDEO: Idelalisib shows promise in refractory non-Hodgkin lymphomaDecember 10, 2013Aggressive Lymphomas
No survival benefit for routine surveillance scans in classical Hodgkin diseaseJuly 8, 2013Indolent Lymphoma
